VOR (STOCKS)
Vor Biopharma Inc. Common Stock
$13.070000
-0.270000 (-2.02%)
Prev close: $13.340000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jean-Paul Kress
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $543.91M
- Employees
- 168
- P/E (TTM)
- -0.03
- P/B (TTM)
- -0.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-3.33 | $-3.28 | -0.0455 | -1.39% |
|
Jun 2025 (Q2)
|
$-43.80 | $-8.86 | -34.9443 | -394.60% |
|
Mar 2025 (Q1)
|
$-5.20 | $-4.62 | -0.5829 | -12.62% |
|
Dec 2024 (Q4)
|
$-8.80 | $-5.77 | -3.0287 | -52.48% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$2.08B |
| Operating Expenses | $366.99M |
| Research and Development | $327.69M |
| Other Operating Expenses | $39.30M |
| Operating Income/Loss | -$366.99M |
| Income/Loss From Continuing Operations After Tax | -$2.45B |
| Income/Loss From Continuing Operations Before Tax | -$2.45B |
| Net Income/Loss | -$2.45B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.45B |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.45B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$110.92 |
| Diluted Earnings Per Share | -$110.92 |
| Basic Average Shares | 197,022,840 |
| Diluted Average Shares | 197,022,840 |
| Assets | $176.24M |
| Current Assets | $172.49M |
| Cash | $170.50M |
| Prepaid Expenses | $747.00K |
| Other Current Assets | $1.24M |
| Noncurrent Assets | $3.75M |
| Fixed Assets | $271.00K |
| Other Non-current Assets | $3.48M |
| Liabilities | $2.40B |
| Current Liabilities | $18.84M |
| Accounts Payable | $885.00K |
| Wages | $3.03M |
| Other Current Liabilities | $14.93M |
| Noncurrent Liabilities | $2.38B |
| Equity | -$2.23B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$2.23B |
| Liabilities And Equity | $176.24M |
| Net Cash Flow From Operating Activities | -$143.98M |
| Net Cash Flow From Operating Activities, Continuing | -$143.98M |
| Net Cash Flow From Investing Activities | $100.00K |
| Net Cash Flow From Investing Activities, Continuing | $100.00K |
| Net Cash Flow From Financing Activities | $249.29M |
| Net Cash Flow From Financing Activities, Continuing | $249.29M |
| Net Cash Flow | $105.42M |
| Net Cash Flow, Continuing | $105.42M |
| Comprehensive Income/Loss | -$2.45B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.45B |
| Other Comprehensive Income/Loss | -$812.73M |
| Other Comprehensive Income/Loss Attributable To Parent | -$56.00K |